{"id":11,"date":"2026-03-04T10:17:57","date_gmt":"2026-03-04T10:17:57","guid":{"rendered":"https:\/\/medi-first-research.de\/?page_id=11"},"modified":"2026-03-18T10:08:56","modified_gmt":"2026-03-18T10:08:56","slug":"mission-vision","status":"publish","type":"page","link":"https:\/\/medi-first-research.de\/en\/mission-vision\/","title":{"rendered":"Mission & Vision"},"content":{"rendered":"
<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n
\n\t

Intentionale Wissenschaft,
\nweil Gesundheit eine Frage der W\u00fcrde ist.<\/span><\/h1>\n<\/div>\n\n\n\n

Medi First R&D is the research and development unit within the Medi First Group. We work where scientific insights must become clinically actionable - at the interface of pharmacological potential, formulation precision, and clinical responsibility. Our focus is cannabinoid-based phytomedicine, aligned with clear target profiles (TPP), robust evidence pathways, and a development logic that makes safety and traceability the benchmark.<\/p>\n<\/div>

We believe in the right to the best possible, evidence-based care.<\/strong> Our mission is not to produce science, but to translate it into care that protects quality of life and enables autonomy. For us, intentional science means that research is never an end in itself. It is a mandate to patients, professional communities, and institutions to make benefits and risks understandable, justifiable, and verifiable.<\/p>\n<\/div>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t

<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n